Medical Services International Completes
Additional Registrations
 

July 5, 2005
Medical Services International Inc. (OTC: MSITF) is pleased to announce that it has received regulatory approval of its VScan Hepatitis C, Tuberculosis (TB) and Syphilis rapid test kits in Ukraine. The company had previously announced approval of its HIV test kit in Ukraine. There is a serious Tuberculosis problem in this part of the world and the fact that there is a rapid test kit for TB that is as accurate as the VScan TB test kit and gives no false positives will be extremely helpful to medical personnel in treating this disease. Tuberculosis is treatable with early diagnosis.
 

The Company is in the process of registering all four test kits in other countries in the general area. The Company is working with its distributor for the area to develop a comprehensive marketing program. The Company expects to receive an initial order in excess of 50,000 kits within the next 30 days.
 

About VScan ™

The VScan™ rapid test kit is a single use, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever and West Nile, Malaria, Syphilis, and Prostate Cancer. The kits cannot be sold in Canada.

For further information contact:
Robert Talbot at 780-430-6363 or
Bill Whitehead, Jr., 416-822-5883

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF".